Ultimately, the procedure, which isnt currently approved by the FDA, is thought to be a safe procedure, although there are a few things to consider
Compounds such as BPC-157 or growth hormone-releasing peptides have been studied primarily in animal models or small, low-quality human studies, and there is currently no high-quality evidence supporting their use for weight management in humans
rPeptide: Best for Recombinant Peptides and Proteins rPeptide builds its catalog by recombinant expression, not chemical synthesis
You have three administration options: Option A: Injectable GHK-Cu only 200 to 600 mcg per day, subcutaneous Best for systemic tissue support (skin, joints, hair, internal tissues) No fasting required Option B: Topical GHK-Cu only Applied to target areas once or twice daily Best for localized skin concerns (face, abdomen, specific areas of laxity) Lower cost, no injection required Option C: Injectable plus topical (recommended for maximum benefit) Injectable for systemic support plus topical for targeted skin areas Most thorough approach Addresses both internal tissue health and external skin quality Step 4: Improve and Maintain As semaglutide is titrated up over the following months, continue GHK-Cu consistently
4 : 743749 Sato N, Iwata S, Nakamura K, Hori T, Mori K and Yodoi J (1995) Thiol-mediated redox regulation of apoptosis